AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

North Carolina, ranked in the top five states for life sciences by Business Facilities, is home to a thriving ecosystem specializing in bio and pharmaceutical manufacturing. Propelled by a low cost of ...

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, and TaiGen Biotechnology, a listed discovery-based and market-focused ...

Prime Medicine, a biotech company that set out to use its more precise approach to gene editing to develop new one-time treatments for rare diseases, is expanding its scope to more prevalent ...

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a look at where Prime Medicine, Inc. (NASDAQ:PRME) stands against the other ...

Enthusiasm for the psychedelic treatment of various mental health disorders, including depression and anxiety, has taken a hit with the FDA’s recent rejection of an MDMA-based therapy for PTSD. This ...

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher Scientific, unpacks the evolving landscape of precision therapeutic and ...

A year ago, medical experts and Nobel Laureates interviewed by The New York Times proclaimed "a Golden Age of Medicine" is here. And in the 12 months since, a flurry of new drug and medical ...

Despite hitting a clinical “milestone,” Prime Medicine is shelving its sole clinical-stage genetic medicine. The Cambridge, Massachusetts-based biotech is also laying off staffers and CEO Keith ...

From the outside looking in, it’s easy to underestimate Topeka, Kansas. But below the surface, the city is poised to make waves in the biotechnology and pharmaceutical industries. Nestled in the heart ...